Investors in Structure Therapeutics Inc (Symbol: GPCR) saw new options become available this week, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is ...
Structure Therapeutics (GPCR) stock jumped 10% after its GLP-1 pill aleniglipron posted 16.3% weight loss, outperforming Lilly and Novo's oral candidates.
In increasingly complex global markets, where volatility and shifting liquidity conditions challenge even experienced market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results